Recently, in a study published in the international magazine Nature, researchers from Newcastle University revealed the molecular mechanism of microbial disruption in the human body using yeast complex carbohydrates, which are the main components of the yeast cell wall. Or to help develop new therapies for the treatment of intestinal diseases.
After 7000 years of evolution, humans have been able to digest all kinds of foods and beverages. However, researchers have surprisingly found that Bacteroides named Bt (Bacteroides thetaiotomicron) can degrade yeast in human intestinal tract. It also brings certain hopes for patients who are accelerating the development of drugs before the origin of life to treat autoimmune diseases and intestinal diseases.
Researcher Gilbert explains that people are generally interested in developing new dietary regimes that include beneficial bacteria, and that when a particular bacterium dominates our gut, it produces molecules that promote the health of the body; Since then, people are interested in developing new types of prebiotics. If we understand the deeper process of complex glycan degradation, the more likely we are to develop complex prebiotics with special beneficial bacteria as targets.
Mannans from yeast cells are the main ingredients in fermented foods in our daily diet, such as bread, beer, wine or soy sauce. Researchers say we can increase the breakdown of yeast cells by stimulating the growth of Bt in the intestines. , thereby increasing the level of mannan in the intestine. The ability of Bt to degrade yeast cells can also help the body to resist yeast infections and autoimmune diseases.
Bt is an important microbial component in the human body. The human body cannot directly digest carbohydrates, and it can be converted into short-chain fatty acids at the end of the intestine to nourish the beneficial bacteria in the intestines, thus maintaining important immunity for the body. The system provides an important barrier.